Liquidia Corporation LQDA Business Segments — Program Expenses

Similar metrics at other companies

OCULSingle Reportable — Research And Development Expense Retina Program One

$42.46M+72.3%

ALMSSingle Reportable — Operating Expenses

$100.15M-15.8%

IMNMSingle Reportable — Operating Expenses

-$59.33M-24.7%

TBPHSingle Reportable — Operating Expenses

$27.18M-8.9%

DWTXSingle Reportable — Operating Expenses

$5.08M+14.6%

SESSingle Reportable — Operating Expenses

$19.08M-31.4%

FAQ

What is Liquidia Corporation's business segments — program expenses?

Liquidia Corporation (LQDA) reported business segments — program expenses of $21.66M in Q1 2026.

How has Liquidia Corporation's business segments — program expenses changed year-over-year?

Liquidia Corporation's business segments — program expenses increased by 64.4% year-over-year, from $13.18M to $21.66M.

What is the long-term trend for Liquidia Corporation's business segments — program expenses?

Over 2 years (2023 to 2025), Liquidia Corporation's business segments — program expenses has grown at a 44.1% compound annual growth rate (CAGR), from $36.35M to $75.48M.

What does business segments — program expenses mean?

This metric captures the direct costs associated with specific research, development, and clinical trial programs within the business segment. It reflects the company's investment in advancing its product pipeline and proprietary technology platforms. Monitoring these expenses helps investors assess the efficiency and progress of the company's R&D initiatives.